Faes Farma SA - Company Profile

Powered by

All the data and insights you need on Faes Farma SA in one report.

  • Save hours of research time and resources with
    our up-to-date Faes Farma SA Strategy Report

  • Understand Faes Farma SA position in the market,
    performance and strategic initiatives.

  • Gain competitive edge and increase your
    chances of success

Back to companies

Faes Farma SA: Segment Analysis

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Business Description

Faes Farma SA (Faes Farma) discovers and develops pharmaceutical products. The company offers prescription drugs, generic drugs, over the counter (OTC) medications, skin-care treatments, food supplements and raw-materials for pharmaceutical use. The company classifies its business into three reportable segments; Pharmaceutical and Healthcare Specialties, Animal Nutrition and Health, and Pharmaceutical Raw Materials.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

R&D Overview

Faes Farma's research and development strategy focuses on uncovering the full potential of innovation and quality in its products, strengthening its presence in key therapeutic areas and enabling new commercial agreements to create synergies with global pharmaceutical companies. The company has over 90 years of global research, production, and marketing of pharmaceutical products. It has more than 100 employees and 30 experts in their research center. The R&D unit of Faes Farma consists of three pillars: biology and medicinal chemistry, pharmaceutical development, and clinical research. The biology and medicinal chemistry unit is responsible for identifying and validating target groups in their therapeutic areas by developing bioassays and characterising and assessing the activities of their drug candidates. The pharmaceutical development unit works on formulation, process science and technology, as well as analytical laboratory techniques. The clinical research unit conducts various types of clinical trials simultaneously, adhering to the most stringent quality standards and following European Regulations and Guidelines, Good Clinical Practices, and FDA regulations.

Business Segments

Overview

Offers nutrition and animal health products through three companies, namely, Ingaso Farm, Technovit and Initial Technical Foods (iTF). All the three companies have been encompassed under the FARM Faes brand by the company.

Performance

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Overview

Offers active pharmaceutical ingredients (APIs), prescription drugs, food supplements, non-prescription drugs and related pharmaceuticals.

Performance

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Overview

Includes items essential for pharmaceutical production.

Performance

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Subscribe for access to business segment analysis Subscribe for access to business segment analysis Find out more



Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer